One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

  • Wijmeersch B Van
  • , T Harrower
  • , J Hobart
  • , R Kizlaitiene
  • , GA Marfia
  • , F Patti
  • , OR Pearson
  • , Pesch V Van
  • , P Vanderdonckt
  • , L Vecsei
  • , S Shor
  • , A Achiron

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - May 2020

Cite this